DBV:EPA
DBV Technologies SA
€1.59
arrow_upward
+1.47%(+0.023) 1D
Oct 19, 4:32:41 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
€1.58
High
€1.61
Low
€1.53
Mkt. cap
498.63M
Avg. vol.
1.11M
Volume
882.61K
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.64
Shares outstanding
314.39M
No. of employees
170
Open
€1.58
High
€1.61
Low
€1.53
Mkt. cap
498.63M
Avg. vol.
1.11M
Volume
882.61K
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.64
Shares outstanding
314.39M
No. of employees
170
News stories
From web sources and news partners
BigGo Finance
·
23 minutes ago
S&P 500, Nasdaq Climb at Open as AI Stocks Rebound; Dow Slips
RealMoney Pro
·
16 minutes ago
Charting the Markets: This Chart of the S&P Is Still Bullish. But for How Long?
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
GuruFocus
·
21 minutes ago
Bank of America Securities Upgrades Dow Inc. (DOW) to Neutral on Rising Chemical Prices
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA